Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Opioids Agonist Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.1% during the forecast period.
This report presents the market size and development trends by detailing the Opioids Agonist Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Opioids Agonist Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Opioids Agonist Drugs industry and will help you to build a panoramic view of the industrial development.
Opioids Agonist Drugs Market, By Type:
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Opioids Agonist Drugs Market, By Application:
Pain Management
Cough Treatment
Diarrhea Treatment
Some of the leading players are as follows:
Sanofi
Sun Pharmaceuticals
Janssen Pharmaceuticals, Inc.
Titan pharmaceuticals
Boehringer Ingelheim
Allergan, Plc
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc
Egalet Corporation
Purdue Pharma
Pfizer Inc
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Opioids Agonist Drugs Market: Technology Type Analysis
-
4.1 Opioids Agonist Drugs Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Opioids Agonist Drugs Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Codeine
4.3.2 Fentanyl
4.3.3 Meperidine
4.3.4 Methadone
4.3.5 Morphine
4.3.6 Hydrocodone
5 Opioids Agonist Drugs Market: Product Analysis
-
5.1 Opioids Agonist Drugs Product Market Share Analysis, 2018 & 2026
-
5.2 Opioids Agonist Drugs Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Opioids Agonist Drugs Market: Application Analysis
-
6.1 Opioids Agonist Drugs Application Market Share Analysis, 2018 & 2026
-
6.2 Opioids Agonist Drugs Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Pain Management
6.3.2 Cough Treatment
6.3.3 Diarrhea Treatment
7 Opioids Agonist Drugs Market: Regional Analysis
-
7.1 Opioids Agonist Drugs Regional Market Share Analysis, 2018 & 2026
-
7.2 Opioids Agonist Drugs Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Sanofi
9.1.1 Sanofi Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Sun Pharmaceuticals
9.2.1 Sun Pharmaceuticals Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Janssen Pharmaceuticals, Inc.
9.3.1 Janssen Pharmaceuticals, Inc. Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Titan pharmaceuticals
9.4.1 Titan pharmaceuticals Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Allergan, Plc
9.6.1 Allergan, Plc Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Mallinckrodt Pharmaceuticals
9.7.1 Mallinckrodt Pharmaceuticals Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Endo Pharmaceuticals Inc
9.8.1 Endo Pharmaceuticals Inc Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Egalet Corporation
9.9.1 Egalet Corporation Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Purdue Pharma
9.10.1 Purdue Pharma Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Pfizer Inc
9.11.1 Pfizer Inc Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
The List of Tables and Figures (Totals 88 Figures and 142 Tables)
Figure Codeine Opioids Agonist Drugs market, 2015 - 2026 (USD Million)
Figure Fentanyl Opioids Agonist Drugs market, 2015 - 2026 (USD Million)
Figure Meperidine Opioids Agonist Drugs market, 2015 - 2026 (USD Million)
Figure Methadone Opioids Agonist Drugs market, 2015 - 2026 (USD Million)
Figure Morphine Opioids Agonist Drugs market, 2015 - 2026 (USD Million)
Figure Hydrocodone Opioids Agonist Drugs market, 2015 - 2026 (USD Million)
Figure Pain Management market, 2015 - 2026 (USD Million)
Figure Cough Treatment market, 2015 - 2026 (USD Million)
Figure Diarrhea Treatment market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Opioids Agonist Drugs market, by country, 2015 - 2026 (USD Million)
-
Table North America Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table North America Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table North America Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Canada Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Canada Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Europe Opioids Agonist Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Europe Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Europe Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Europe Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Germany Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Germany Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table France Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table France Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Italy Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Italy Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Spain Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Spain Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Opioids Agonist Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table China Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table China Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Japan Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Japan Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table India Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table India Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Opioids Agonist Drugs market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table MEA Opioids Agonist Drugs market, by country, 2015 - 2026 (USD Million)
-
Table MEA Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table MEA Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table MEA Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Opioids Agonist Drugs market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Opioids Agonist Drugs market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Opioids Agonist Drugs market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sun Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Janssen Pharmaceuticals, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Titan pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Allergan, Plc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mallinckrodt Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Endo Pharmaceuticals Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Egalet Corporation Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Purdue Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
